Thymoquinone and its Nanoformulation Attenuate Colorectal and Breast Cancers and Alleviate Doxorubicin-Induced Cardiotoxicity

References

• El-Far AH , DarwishNHE, MousaSA. Senescent Colon and breast cancer cells induced by doxorubicin exhibit enhanced sensitivity to curcumin, caffeine, and thymoquinone. Integr. Cancer Ther.19, doi: 10.1177/1534735419901160 (2020).
   PubMed Web of Science ®Google Scholar
• Sudha T , El-FarAH, MousaDS, MousaSA. Resveratrol and its nanoformulation attenuate growth and the angiogenesis of xenograft and orthotopic colon cancer models. Molecules25(6), 1412 (2020).
   PubMed Web of Science ®Google Scholar
• Mousa DS , El-FarAH, SaddiqAA, SudhaT, MousaSA. Nanoformulated bioactive compounds derived from different natural products combat pancreatic cancer cell proliferation. Int. J. Nanomed.15, 2259–2268 (2020).
   PubMed Web of Science ®Google Scholar
• Wachtel-Galor S . BenzieIFF. Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs. In: Herbal Medicine: Biomolecular and Clinical Aspects (Second Edition).Wachtel-GalorS, BenzieIFF ( Eds). CRC Press, FL, USA (2011).
   Google Scholar
• El-Far AH , KorshomMA, MandourAA, El-BessoumyAA, El-SayedYS. Hepatoprotective efficacy of Nigella sativa seeds dietary supplementation against lead acetate-induced oxidative damage in rabbit – purification and characterization of glutathione peroxidase. Biomed. Pharmacother.89, 711–718 (2017).
   PubMed Web of Science ®Google Scholar
• Atta MS , El-FarAH, FarragFA, Abdel-DaimMM, AlJaouni SK, MousaSA. Thymoquinone attenuates cardiomyopathy in streptozotocin-treated diabetic rats. Oxid. Med. Cell. Longev.2018, 1–10 (2018).
   Web of Science ®Google Scholar
• El-Far AH , BadriaFA, ShaheenHM. Possible anticancer mechanisms of some costus speciosus active ingredients concerning drug discovery. Curr. Drug Discov. Technol.13(3), 123–143 (2016).
   PubMedGoogle Scholar
• El-Far A . Thymoquinone anticancer discovery: possible mechanisms. Curr. Drug Discov. Technol.12(2), 80–89 (2015).
   PubMedGoogle Scholar
• El-Far AH , AlJaouni SK, LiW, MousaSA. Protective roles of thymoquinone nanoformulations: potential nanonutraceuticals in human diseases. MDPI, AG (2018).
   Google Scholar
• Imani S , WeiC, ChengJet al. MicroRNA-34a targets epithelial to mesenchymal transitioninducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Oncotarget8(13), 21362–21379 (2017).
   PubMedGoogle Scholar
• Li J , KhanMA, WeiCet al. Thymoquinone inhibits the migration and invasive characteristics of cervical cancer cells SiHa and CaSki in vitro by targeting epithelial to mesenchymal transition associated transcription factors Twist1 and Zeb1. Molecules22(12), 2105 (2017).
   PubMed Web of Science ®Google Scholar
• Chen MC , LeeNH, HsuHHet al. Thymoquinone induces caspase-independent, autophagic cell death in cpt-11-resistant LoVo colon cancer via mitochondrial dysfunction and activation of JNK and p38. J. Agric. Food Chem.63(5), 1540–1546 (2015).
   PubMed Web of Science ®Google Scholar
• El-Najjar N , ChatilaM, MoukademHet al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis15(2), 183–195 (2009).
   Web of Science ®Google Scholar
• Zhang L , BaiY, YangY. Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB. Oncol. Lett.12(4), 2840–2845 (2016).
   PubMed Web of Science ®Google Scholar
• Kundu J , ChoiBY, JeongCH, KunduJK, ChunKS. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src-mediated phosphorylation of EGF receptor tyrosine kinase. Oncol. Rep.32(2), 821–828 (2014).
   PubMed Web of Science ®Google Scholar
• Ünal TD , HamurcuZ, DelibaşıNet al. Thymoquinone inhibits proliferation and migration of MDA-MB-231 triple negative breast cancer cells by suppressing autophagy and Beclin-1 and LC3. Anticancer. Agents Med. Chem.20 (2020).
   Web of Science ®Google Scholar
• Kabil N , BayraktarR, KahramanNet al. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Res. Treat.171(3), 593–605 (2018).
   PubMed Web of Science ®Google Scholar
• Bachur NR . Anthracyclines. In: Encyclopedia of Cancer.BertinoJ ( Ed.). Academic Press, MA, USA, 57–61 (2002).
   Google Scholar
• Fornari FA , RandolphJK, YalowichJC, RitkeMK, GewirtzDA. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol. Pharmacol.45(4), 649–656 (1994).
   PubMed Web of Science ®Google Scholar
• Rivankar S . An overview of doxorubicin formulations in cancer therapy. J. Cancer Res. Ther.10(4), 853 (2014).
   PubMed Web of Science ®Google Scholar
• Waterhouse DN , TardiPG, MayerLD, BallyMB. A comparison of liposomal formulations of doxorubicin with Drug Administered in free form: changing toxicity profiles. Drug Saf.24(12), 903–920 (2001).
   PubMedGoogle Scholar
• Almuhayawi MS , RamadanWS, HarakehSet al. The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model. Saudi J. Biol. Sci.27(7), 1710–1716 (2020).
   PubMed Web of Science ®Google Scholar
• Sudha T , BharaliDJ, YalcinMet al. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. Int. J. Nanomed.12, 1305–1315 (2017).
   PubMed Web of Science ®Google Scholar
• Li W , YalcinM, BharaliDJet al. Pharmacokinetics, biodistribution, and anti-angiogenesis efficacy of diamino propane tetraiodothyroacetic acid-conjugated biodegradable polymeric nanoparticle. Sci. Rep.9(1), 9006 (2019).
   PubMedGoogle Scholar
• Ma X , YuH. Cancer Issue: global burden of cancer. Yale J. Biol. Med.79(3–4), 85 (2006).
   PubMedGoogle Scholar
• Word Health Organisation . Global health estimates technical paper.WHO Press, Geneva, Switzerland (2000).
   Google Scholar
• Godugu K , El-FarAH, AlJaouni S, MousaSA. Nanoformulated ajwa (Phoenix dactylifera) bioactive compounds improve the safety of doxorubicin without compromising its anticancer efficacy in breast cancer. Molecules25(11), 2597 (2020).
   PubMed Web of Science ®Google Scholar
• Subramaniam S , SelvadurayKR, RadhakrishnanAK. Bioactive compounds: natural defense against cancer?Biomolecules9(12), 758 (2019).
   PubMed Web of Science ®Google Scholar
• Hsu HH , ChenMC, DayCHet al. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation. World J. Gastroenterol.23(7), 1171–1179 (2017).
   PubMed Web of Science ®Google Scholar
• Arafa E-SASA , ZhuQ, ShahZIet al. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. 706(1–2), 28–35 (2011).
   Google Scholar
• Effenberger-Neidnicht K , SchobertR. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother. Pharmacol.67(4), 867–874 (2010).
   PubMed Web of Science ®Google Scholar
• Ibiyeye KM , NordinN, AjatM, ZukiABZ. Ultrastructural changes and antitumor effects of doxorubicin/thymoquinone-loaded CaCO3 nanoparticles on breast cancer cell line. Front. Oncol.9, 599 (2019).
   PubMed Web of Science ®Google Scholar
• Ibiyeye KM , ZukiABZ. Cockle shell-derived aragonite CaCO3 nanoparticles for co-delivery of doxorubicin and thymoquinone eliminates cancer stem cells. Int. J. Mol. Sci.21(5), 1900 (2020).
   PubMed Web of Science ®Google Scholar
• El-Ashmawy NE , KhedrEG, EbeidE-ZM, SalemML, ZidanA-AA, MosalamEM. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma. Eur. J. Pharm. Sci.109, 525–532 (2017).
   PubMed Web of Science ®Google Scholar
• Koleini N , KardamiE. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Oncotarget8(28), 46663–46680 (2017).
   PubMedGoogle Scholar
• Karabulut D , OzturkE, KaymakE, AkinAT, YakanB. Thymoquinone attenuates doxorubicin-cardiotoxicity in rats. J. Biochem. Mol. Toxicol.35(1), e22618 (2021).
   PubMed Web of Science ®Google Scholar
• Alam MF , KhanG, SafhiMMet al. Thymoquinone ameliorates doxorubicin-induced cardiotoxicity in Swiss albino mice by modulating oxidative damage and cellular inflammation. Cardiol. Res. Pract.2018, 1–6 (2018).
   Web of Science ®Google Scholar
• Brown RK , WilsonG, TucciMA, BenghuzziHA. The effects of thymoquinone and Doxorubicin on leukemia and cardiomyocyte cell lines. Biomed. Sci. Instrum.50, 391–396 (2014).
   PubMedGoogle Scholar
• Nagi MN , MansourMA. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res.41(3), 283–289 (2000).
   PubMed Web of Science ®Google Scholar